Invesco QQQ Trust, Series 1 (QQQ)
Latest news, insights and market data
Market Data
AI Insights
No news
Latest News
| Title | Published |
|---|---|
International Markets Are Pulling Ahead Of US Stocks In 2026: These 4 ETFs Have Left SPY, QQQ, DIA In The Dust International Markets Are Pulling Ahead Of US Stocks In 2026: These 4 ETFs Have Left SPY, QQQ, DIA In The Dust | 17 minutes ago |
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist | about 2 hours ago |
The 60/40 Portfolio Looks Dead Again: Here's What To Do The recent surge in stock-bond correlations has reignited concerns about the effectiveness of the 60/40 portfolio strategy. Click here to read more. | about 21 hours ago |
My Biggest Warning For Anyone Who Owns The S&P 500 The S&P 500 delivered exceptional 15-year returns, but its primary return enginesâlow rates and earnings growthâare now weakening. Click for more on SPY. | about 22 hours ago |
Nearly All of QQQI’s Yield Was Return of Capital, Not Income. Here Is What That Does to Your Cost Basis Nearly All of QQQI’s Yield Was Return of Capital, Not Income. Here Is What That Does to Your Cost Basis | 1 day ago |
Nearly All of QQQI’s Yield Was Return of Capital, Not Income. Here Is What That Does to Your Cost Basis QQQI sends monthly cash to investors, but the IRS form filed by the fund tells a very different story about where that money actually comes from and what it quietly does to your cost basis every time a payment hits your account. | 1 day ago |
Is the AI Bull Market About to Crash? This Risk Indicator Is Saying Yes Is the AI Bull Market About to Crash? This Risk Indicator Is Saying Yes | 1 day ago |
International Markets Are Pulling Ahead Of US Stocks In 2026: These 4 ETFs Have Left SPY, QQQ, DIA In The Dust
International Markets Are Pulling Ahead Of US Stocks In 2026: These 4 ETFs Have Left SPY, QQQ, DIA In The Dust
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist
Stocktwits Pharma Pulse: Roche Faces FDA Decision, Gene-Therapy Stocks Step Into Focus — The Week’s Biotech Watchlist
The 60/40 Portfolio Looks Dead Again: Here's What To Do
The recent surge in stock-bond correlations has reignited concerns about the effectiveness of the 60/40 portfolio strategy. Click here to read more.
My Biggest Warning For Anyone Who Owns The S&P 500
The S&P 500 delivered exceptional 15-year returns, but its primary return enginesâlow rates and earnings growthâare now weakening. Click for more on SPY.
Nearly All of QQQI’s Yield Was Return of Capital, Not Income. Here Is What That Does to Your Cost Basis
Nearly All of QQQI’s Yield Was Return of Capital, Not Income. Here Is What That Does to Your Cost Basis
Nearly All of QQQI’s Yield Was Return of Capital, Not Income. Here Is What That Does to Your Cost Basis
QQQI sends monthly cash to investors, but the IRS form filed by the fund tells a very different story about where that money actually comes from and what it quietly does to your cost basis every time a payment hits your account.
Is the AI Bull Market About to Crash? This Risk Indicator Is Saying Yes
Is the AI Bull Market About to Crash? This Risk Indicator Is Saying Yes